STIFEL FINANCIAL CORP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$178,000
+5.3%
12,176
+2.6%
0.00%
Q3 2020$169,000
-30.5%
11,867
-28.3%
0.00%
-100.0%
Q2 2020$243,000
+12.5%
16,548
-68.3%
0.00%0.0%
Q1 2020$216,000
+71.4%
52,233
+102.5%
0.00%
Q4 2019$126,000
-3.8%
25,793
+19.6%
0.00%
Q3 2019$131,00021,5690.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders